This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
5mg | $78 | 3-6 Days |
10mg | $120 | 3-6 Days |
25mg | $199 | 3-6 Days |
50mg | $289 | 3-6 Days |
100mg | $450 | 3-6 Days |
250mg | $779 | 3-6 Days |
500mg | $1070 | 3-6 Days |
Cat #: V2247 CAS #: 2109414-84-6 Purity ≥ 98%
Description: Laduviglusib (CHIR-99021; CHIR99021) 2HCl, the dihydrochloride of CHIR-99021, is a potent and selective inhibitor of glycogen synthase kinase 3α/β (GSK-3α/β) with IC50s of 10 nM and 6.7 nM, respectively. Reference: PLoS One. 2013;8(3):e58501.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
CAS No. | 2109414-84-6 |
---|
Protocol | Animal model | Female db/db mice or male ZDF rats with type 2 diabetes |
---|---|---|
Formulation | Formulated as solutions in 20 mM citrate-buffered 15% Captisol or as fine suspensions in 0.5% carboxymethylcellulose. | |
Dosages | 48 mg/kg | |
Administration | Oral gavage |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.